Antibody blood tests, also called serologic tests, check your blood for antibodies that would show if you have had a previous infection. Antibodies are proteins that help fight off germs. A serologic test may not be able to show if you have a current infection, because it can take 1 to 3 weeks to make antibodies after symptoms occur.

We do not know yet if having antibodies to SARS-CoV-2 can protect someone from getting infected with that virus again, or how long that protection might last. Scientists are doing studies to answer those questions.
If you test positive or negative for COVID-19, no matter the type of test, you still should take preventive measures to protect yourself and others. *

*https://www.cdc.gov/coronavirus/2019-ncov/testing/serology-overview.html

If you believe you have been exposed to COVID-19 or have had symptoms in the past, you may be a good candidate for this test. You must be asymptomatic (free of symptoms) for at least seven (7) days prior to testing.

This test requires a simple finger stick.

No, fasting is not required. There are no dietary or medicinal restrictions to take this test.

Any Lab Test Now’s ordering physician will provide the required physician’s order on your behalf.

Results from the COVID-19 IgG/IgM test are generally available within 15 minutes

You can share your results with your healthcare provider or contact our telemedicine partner, DialCare, and they will assist you in interpreting the results. Any Lab Test Now does not diagnose or interpret results.

Early after infection (usually after the first week), a class of antibodies known as immunoglobulin M (IgM) develop, although they typically do not last long. Later, after the first 2-4 weeks following infection, IgG, a more durable antibody, is produced.

Detection of microbe-specific IgM and IgG in circulating blood (a ‘serologic’ test) serves as a traditional method to determine whether a person has been infected with that pathogen, either recently (IgM) or more distantly (IgG).**

**https://www.vumc.org/coronavirus/latest-news/antibody-testing-covid-19-what-it-tells-us-and-what-it-doesnt

Antibody tests can play a critical role in the fight against COVID-19 by helping healthcare professionals identify individuals who have been exposed to SARS-CoV-2 virus and may have develop an immune response. In the future, this may potentially be used to help determine, together with other clinical data, whether these individuals may be less susceptible to infection. ****

****https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-diagnostic-testing-sars-cov-2

No, but it has been granted FDA EUA authorization. During a public health emergency, the FDA can use its Emergency Use Authorization (EUA) to provide more timely access to critical medical products that may help during the emergency when there are no adequate, approved, and available options.

According to the FDA “more flexibility was needed during a pandemic of this scale and speed, and incorporating feedback from the medical community, states and test developers, we have also provided regulatory flexibility for serological tests in an effort to provide laboratories and health care providers with early access to these tests with the understanding that the FDA had not reviewed or authorized (or “approved”) them, at least not initially, and these tests should not be used for diagnosing or excluding active SARS-CoV-2 infection. Specifically, last month, as part of our broader strategy, the FDA issued a policy explaining that FDA does not intend to object when developers of serological tests market or use their tests without prior FDA review where: 1) the tests are validated by the developer to determine that they are accurate and reliable, 2) notification of the developer’s validation is provided to FDA, and 3) the tests are labeled appropriately, including that they are not to be used as a sole basis for diagnosis. “***

The test you receive follows the above referenced FDA guidelines.

***https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-serological-test-validation-and-education-efforts

COVID-19 Antibody Testing should not be the sole determination for staffing. Since the we do not know if COVID-19 antibodies protect someone from future infection, you cannot be assured that they will not get re-infected.

If you have a positive test result, it is likely that you may have had COVID-19 and might have developed an antibody response to the virus. There is a small chance that this test can give a positive result that is wrong (a false positive result). *

*https://www.cdc.gov/coronavirus/2019-ncov/testing/serology-overview.html

A negative test results means that the antibodies to the virus that causes COVID-19 were not found in your sample. However, it is possible for this test to give a negative result that is incorrect (false negative) in some people with COVID-19. A negative result may occur if you are tested early in your illness and your body hasn’t had time to produce antibodies to infection. This means that you could possibly still have COVID-19 even though the test is negative. ***

***https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-serological-test-validation-and-education-efforts

You can share your results with your healthcare provider or contact our telemedicine partner, DialCare, and they will assist you in interpreting the results. Any Lab Test Now does not diagnose or interpret results.

Free options for testing are available. The COVID-19 Antibody Test may be covered by your insurance plan or the government, with no out-of-pocket costs to you.  If you are interested in this option, please contact your healthcare provider. Any Lab Test Now provides transparent pricing and an option for consumers who want fast and convenient access to laboratory testing. Please note that you can use your HSA or FSA for the cost of the test.